drugset
Drugs / R21-Matrix/M Vaccine (malaria vaccine)
last change Jan 2026 re-read 2 minutes ago

R21-Matrix/M Vaccine (malaria vaccine)

Vaccine

Investigated by
Faculty of Medical Sciences, Radboud University of Medical Center · Jomo Kenyatta University of Agriculture and Technology · National Institute for Public Health and the Environment (RIVM) · Nicole Stoffel · University of Oxford - Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences

Trials 1 · a red edge is where a trial was stopped

today NCT06816524 · not/applicable
202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06816524 Jan 2026 → Dec 2027 expected disorder of iron metabolism and transport Nicole Stoffel Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as R21-Matrix/M Vaccine (malaria vaccine) ClinicalTrials.gov intervention name — accepted as the source's own label NCT06816524 ↗
Modality Vaccine “Biological: R21-Matrix/M Vaccine (malaria vaccine)” NCT06816524 ↗